Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger M Nitsch

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Neuron|December 14, 2019
Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse ModelLien Nguyen, Fabio Montrasio, Amrutha Pattamatta, et al.
Alzheimer'S Research & Therapy|April 1, 2017
Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer's diseaseFrances C Quevenco, Maria G Preti, Jiri M G van Bergen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 4, 2018
Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injuryAlexander Akhmedov, Nicole R Bonetti, Martin F Reiner, et al.
Nature|September 2, 2016
The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Nature|June 23, 2017
Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Neurogenetics|March 28, 2007
Association study of cholesterol-related genes in Alzheimer's diseaseM Axel Wollmer, Kristel Sleegers, Martin Ingelsson, et al.
Neuro-Degenerative Diseases|August 16, 2006
Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's diseaseAndreas Papassotiropoulos, Jean-Charles Lambert, Fabienne Wavrant-De Vrièze, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2022
Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of <i>C9orf72</i> diseaseMelanie Jambeau, Kevin D Meyer, Marian Hruska-Plochan, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Neuron|December 14, 2019
Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse ModelLien Nguyen, Fabio Montrasio, Amrutha Pattamatta, et al.
Alzheimer'S Research & Therapy|April 1, 2017
Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer's diseaseFrances C Quevenco, Maria G Preti, Jiri M G van Bergen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 4, 2018
Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injuryAlexander Akhmedov, Nicole R Bonetti, Martin F Reiner, et al.
Nature|September 2, 2016
The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Nature|June 23, 2017
Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseJeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Neurogenetics|March 28, 2007
Association study of cholesterol-related genes in Alzheimer's diseaseM Axel Wollmer, Kristel Sleegers, Martin Ingelsson, et al.
Neuro-Degenerative Diseases|August 16, 2006
Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's diseaseAndreas Papassotiropoulos, Jean-Charles Lambert, Fabienne Wavrant-De Vrièze, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2022
Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of <i>C9orf72</i> diseaseMelanie Jambeau, Kevin D Meyer, Marian Hruska-Plochan, et al.
Pageof 17